These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18592337)

  • 1. [Hormonal contraceptives--an ongoing matter of research. Statement on the paper of C. Giersig: Progestin and breast cancer. The missing pieces of a puzzle].
    Löwer J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):779-81. PubMed ID: 18592337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestin and breast cancer. The missing pieces of a puzzle.
    Giersig C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):782-6. PubMed ID: 18592338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
    N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Shapiro S
    Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer and oral contraceptives: critique of the proposition that high potency progestogen products confer excess risk.
    Sturtevant FM
    Biomed Pharmacother; 1984; 38(8):371-9. PubMed ID: 6525434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighing the Risks and Benefits of Hormonal Contraception.
    Peachman RR
    JAMA; 2018 Mar; 319(11):1083-1084. PubMed ID: 29490363
    [No Abstract]   [Full Text] [Related]  

  • 8. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives.
    Burke AE
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S14-7. PubMed ID: 21961819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer of the breast. Influence of hormonal contraception].
    Gorins A
    Presse Med; 1984 May; 13(19):1207-10. PubMed ID: 6232568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestins and risk of breast cancer. Much ado about nothing?
    Gorins A
    Eur J Gynaecol Oncol; 2003; 24(5):345-50. PubMed ID: 14584641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):143-7. PubMed ID: 23578274
    [No Abstract]   [Full Text] [Related]  

  • 12. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
    Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
    Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives.
    Merki-Feld GS; Apter D; Bartfai G; Grandi G; Haldre K; Lech M; Lertxundi R; Lete I; Lobo Abascal P; Raine S; Roumen F; Serfaty D; Shulman LP; Skouby S; Bitzer J
    Eur J Contracept Reprod Health Care; 2017 Aug; 22(4):247-249. PubMed ID: 28728451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral contraceptives and breast cancer].
    Zoricić D; Ambrozić B; Perić D
    Lijec Vjesn; 1998 Dec; 120(12):392-7. PubMed ID: 19658362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal contraceptives and their relationship to breast cancer].
    Habánová M; Svikruhová J; Sláviková E
    Klin Onkol; 2010; 23(6):428-32. PubMed ID: 21351420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal breast physiology: the reasons hormonal contraceptives and induced abortion increase breast-cancer risk.
    Lanfranchi A
    Issues Law Med; 2014; 29(1):135-46. PubMed ID: 25189013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Awareness of the influence of progestin contraceptives on bone mineral content].
    Jamin C
    Presse Med; 2002 Nov; 31(37 Pt 1):1731-2. PubMed ID: 12489314
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X; Seeger H; Mueck AO
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.